[Inflammatory breast carcinoma and prognosticators of efficacy of primary chemotherapy].
The efficacy of primary chemotherapy for inflammatory breast carcinoma (IBC) was studied vis-a-vis certain symptoms characterizing patient's status and biological features of tumor. It was shown that such factors as estrogen (ER) and progesterone (PR) receptor status and malignancy grade of tumor can be used to predict the efficacy. Negative ER/PR status plus high malignancy grade involved higher frequency of complete pathomorphological responses. Worst prognosis was in patients under 35 years of age, with ductal BC and negative ER/PR status of tumor.
Semiglazov
V F
VF
Zernov
K Iu
KIu
Bozhok
A A
AA
Petrovskiĭ
S G
SG
Ivanova
O A
OA
Orlov
A A
AA
Barash
N Iu
NIu
Paltuev
R M
RM
Donskikh
R V
RV
Damenia
A O
AO
Kletsel'
A E
AE
Kochetova
I A
IA
Efimenko
A V
AV
D000328:Adult; D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000473:pathology; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D016019:Survival Analysis; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone